-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Shuttle Pharmaceuticals Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2021 to Q3 2024.
- Shuttle Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$733K, a 278% decline year-over-year.
- Shuttle Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$1.98M, a 21.6% increase year-over-year.
- Shuttle Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was -$700K, a 73.6% increase from 2022.
- Shuttle Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$2.65M, a 549% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)